Vicarious Surgical CFO to Step Down

Dow Jones

Dec 07, 2024

By Sarina Isaacs

Vicarious Surgical on Friday said William Kelly is stepping down from his role as chief financial officer.

The Waltham, Mass.-based robotics company said Kelly, who is leaving to pursue other professional opportunities, will stay on until Jan. 2 to help the company transition his responsibilities.

Kelly has been Vicarious Surgical's CFO since January 2021. He was previously CFO at Exosome Diagnostics, a privately held life science company; and CFO at life sciences company Repligen Corp. before that. As CFO at Vicarious, his total compensation in 2023 was $1.6 million.

Vicarious said it has initiated a succession process and will provide updates as appropriate.

Write to Sarina Isaacs at sarina.isaacs@wsj.com

(END) Dow Jones Newswires

December 06, 2024 16:30 ET (21:30 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2489261265"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2489261265\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2489261265?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-07 05:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489261265","market":"hk","top_or_hot":-1,"title":"Vicarious Surgical CFO to Step Down","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sarina Isaacs \n</p>\n<pre>\n \n</pre>\n<p>\n  Vicarious Surgical on Friday said William Kelly is stepping down from his role as chief financial officer. \n</p>\n<p>\n  The Waltham, Mass.-based robotics company said Kelly, who is leaving to pursue other professional opportunities, will stay on until Jan. 2 to help the company transition his responsibilities. \n</p>\n<p>\n  Kelly has been Vicarious Surgical's CFO since January 2021. He was previously CFO at Exosome Diagnostics, a privately held life science company; and CFO at life sciences company Repligen Corp. before that. As CFO at Vicarious, his total compensation in 2023 was $1.6 million. \n</p>\n<p>\n  Vicarious said it has initiated a succession process and will provide updates as appropriate. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sarina Isaacs at sarina.isaacs@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 06, 2024 16:30 ET (21:30 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vicarious Surgical CFO to Step Down</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVicarious Surgical CFO to Step Down\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-12-07 05:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Sarina Isaacs \n</p>\n<pre>\n \n</pre>\n<p>\n  Vicarious Surgical on Friday said William Kelly is stepping down from his role as chief financial officer. \n</p>\n<p>\n  The Waltham, Mass.-based robotics company said Kelly, who is leaving to pursue other professional opportunities, will stay on until Jan. 2 to help the company transition his responsibilities. \n</p>\n<p>\n  Kelly has been Vicarious Surgical's CFO since January 2021. He was previously CFO at Exosome Diagnostics, a privately held life science company; and CFO at life sciences company Repligen Corp. before that. As CFO at Vicarious, his total compensation in 2023 was $1.6 million. \n</p>\n<p>\n  Vicarious said it has initiated a succession process and will provide updates as appropriate. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Sarina Isaacs at sarina.isaacs@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 06, 2024 16:30 ET (21:30 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RBOT","symbol_name":"Vicarious Surgical Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2489261265","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489261265","pubTimestamp":1733520600,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Vicarious Surgical on Friday said William Kelly is stepping down from his role as chief financial officer.The Waltham, Mass.-based robotics company said Kelly, who is leaving to pursue other professional opportunities, will stay on until Jan. 2 to help the company transition his responsibilities.Kelly has been Vicarious Surgical's CFO since January 2021. He was previously CFO at Exosome Diagnostics, a privately held life science company; and CFO at life sciences company Repligen Corp. before that. As CFO at Vicarious, his total compensation in 2023 was $1.6 million.Vicarious said it has initiated a succession process and will provide updates as appropriate.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RBOT":"Vicarious Surgical Inc.","BK4082":"医疗保健设备"},"translate_title":"Vicarious Surgical首席财务官辞职","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RBOT":0.9},"content_text":"By Sarina Isaacs \n\n\n \n\n\n  Vicarious Surgical on Friday said William Kelly is stepping down from his role as chief financial officer. \n\n\n  The Waltham, Mass.-based robotics company said Kelly, who is leaving to pursue other professional opportunities, will stay on until Jan. 2 to help the company transition his responsibilities. \n\n\n  Kelly has been Vicarious Surgical's CFO since January 2021. He was previously CFO at Exosome Diagnostics, a privately held life science company; and CFO at life sciences company Repligen Corp. before that. As CFO at Vicarious, his total compensation in 2023 was $1.6 million. \n\n\n  Vicarious said it has initiated a succession process and will provide updates as appropriate. \n\n\n \n\n\n  Write to Sarina Isaacs at sarina.isaacs@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 06, 2024 16:30 ET (21:30 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}